Capital Analysts, LLC Amarin Corp Plcuk Call Options Transaction History
Capital Analysts, LLC
- $2.68 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMRN
# of Institutions
154Shares Held
70MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$261 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$131 Million9.37% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$35.8 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$27.6 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$26.5 Million5.52% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.24B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...